BCL11B and neoplasm: The therapeutic relevance of this regulatory axis is underscored by experiments showing that inhibition of NF-κB/Jak-Stat signaling with TPCA-1 can rescue the aging phenotype and significantly reduce tumor incidence in Bcl11b-deficient models.